the first generic raltegravir medicines
Published on 19 Jul 2024 · source: MHRA — Medicines and Healthcare products Regulatory Agency
What this means
The MHRA has announced the approval of a medicine or a new indication in the UK. Approval does not mean the product is already available on the NHS: NICE appraisal and commissioning may follow.
Summary
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 July 2024, approved the first generic raltegravir medicines to treat adult and paediatric HIV patients who weigh at least 40kg.